Drug Trial Radar · NCT02694978
A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Last checked: Nov 20, 2026Latest source record: Jul 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,014
Actual
Start
Feb 29, 2016
Primary completion
Jan 16, 2017
Study completion Jul 17, 2017
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety of 1.020 grams (g) of intravenous (IV) ferumoxytol compared to 1.500 g of IV ferric carboxymaltose (FCM).
Conditions
- Iron Deficiency Anemia
Interventions
FerumoxytolDrug
FCMDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants With Treatment-Emergent (TE) Moderate To Severe Hypersensitivity Reactions (Rxns), Including Anaphylaxis, Or Moderate To Severe HypotensionTime frame: Day 1 (after first dosing) through Week 5
Locations
127 sites in 7 countries. Site status is shown where the registry gives one.
Clinical Trial Site
Huntsville, Alabama
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Tucson, Arizona
Clinical Trial Site
Anaheim, California
Clinical Trial Site
Chula Vista, California
Clinical Trial Site
Corona, California
Clinical Trial Site
Encino, California
Clinical Trial Site
Fountain Valley, California
Clinical Trial Site
Granada Hills, California
Clinical Trial Site
La Mesa, California
Clinical Trial Site
Orange, California
Clinical Trial Site
Oxnard, California
Clinical Trial Site
Riverside, California
Clinical Trial Site
San Diego, California
Clinical Trial Site
West Hollywood, California
Clinical Trial Site
Westminster, California
Clinical Trial Site
Bristol, Connecticut
Clinical Trial Site
Norwalk, Connecticut
Clinical Trial Site
Clearwater, Florida
Clinical Trial Site
Gainesville, Florida
Clinical Trial Site
Lauderdale Lakes, Florida
Clinical Trial Site
Lauderdale Lakes, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Miami Lakes, Florida
Clinical Trial Site
North Miami, Florida
Clinical Trial Site
South Miami, Florida
Clinical Trial Site
West Palm Beach, Florida
Clinical Trial Site
Winter Haven, Florida
Clinical Trial Site
Atlanta, Georgia
Clinical Trial Site
Augusta, Georgia
Clinical Trial Site
Savannah, Georgia
Clinical Trial Site
Thomasville, Georgia
Clinical Trial Site
Elk Grove Village, Illinois
Clinical Trial Site
Evergreen Park, Illinois
Clinical Trial Site
Hazel Crest, Illinois
Clinical Trial Site
Skokie, Illinois
Clinical Trial Site
Skokie, Illinois
Clinical Trial Site
Wichita, Kansas
Clinical Trial Site
Crestview Hills, Kentucky
Showing 40 of 127 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.